Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Title: Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Volume: 1 Issue: 2

Author(s): A. McDonnel Smedts, T. E. Curry Jr. and W. J. Murdoch

Affiliation:

Keywords: matrix metalloproteinase, urokinase, kallikrein, ovarian cancer, protease inhibitor

Abstract: Common (surface) epithelial cancer of the ovary is epitomized by metastasis to organs of the abdominal cavity. Proteolytic enzymes, predominately those of the matrix metalloproteinase and plasminogen activator-plasmin systems, have been implicated as mediators of tissue invasion. This review highlights the salient features of ovarian cancer progression, the proteases involved, and experimental approaches of inhibition. Enzyme inhibitors hold promise in the treatment of early-stage and recurrent (following cytoreductive surgery) disease.

Cite this article as:

Smedts McDonnel A., Curry Jr. E. T. and Murdoch J. W., Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer, Current Enzyme Inhibition 2005; 1 (2) . https://dx.doi.org/10.2174/1573408054022199